Cargando…

Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study

Major depressive disorder (MDD) is a debilitating psychiatric illness. However, there is currently no objective laboratory-based diagnostic tests for this disorder. Although, perturbations in multiple neurotransmitter systems have been implicated in MDD, the biochemical changes underlying the disord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Jun-Xi, Xia, Jin-Jun, Deng, Feng-Li, Liang, Wei-Wei, Wu, Jing, Yin, Bang-Min, Dong, Mei-Xue, Chen, Jian-Jun, Ye, Fei, Wang, Hai-Yang, Zheng, Peng, Xie, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039504/ https://www.ncbi.nlm.nih.gov/pubmed/29991685 http://dx.doi.org/10.1038/s41398-018-0183-x

Ejemplares similares

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui, Si-Wen, et al.
Publicado: (2018)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Compressed primary‐to‐transmodal gradient is accompanied with subcortical alterations and linked to neurotransmitters and cellular signatures in major depressive disorder
por: Xiao, Yang, et al.
Publicado: (2023)

Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders
por: Jiang, Yao, et al.
Publicado: (2022)

Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder
por: Zhang, Han-ping, et al.
Publicado: (2020)

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder
por: Wu, Zhonghao, et al.
Publicado: (2022)

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
por: Jiang, Yuanliang, et al.
Publicado: (2022)

Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
por: Wei, Mengying, et al.
Publicado: (2019)

Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques
por: Deng, Feng-Li, et al.
Publicado: (2019)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders
por: Liu, Yi, et al.
Publicado: (2018)

Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder
por: Shao, Xiaojun, et al.
Publicado: (2020)

Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
por: Alharbi, Homood, et al.
Publicado: (2021)

Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice
por: Zhou, Manfei, et al.
Publicado: (2023)

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
por: Wei, Mengying, et al.
Publicado: (2021)

Brain Neurotransmitter Modulation by Gut Microbiota in Anxiety and Depression
por: Huang, Fei, et al.
Publicado: (2021)

Development and Validation of a Plasma FAM19A5 and MRI-Based Radiomics Model for Prediction of Parkinson’s Disease and Parkinson’s Disease With Depression
por: Li, Xue-ning, et al.
Publicado: (2021)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
por: Tu, Zhe, et al.
Publicado: (2018)

Associations Between Disordered Microbial Metabolites and Changes of Neurotransmitters in Depressed Mice
por: Xie, Jing, et al.
Publicado: (2022)

Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls
por: Homorogan, C., et al.
Publicado: (2022)

Modeling the glutamate–glutamine neurotransmitter cycle
por: Shen, Jun
Publicado: (2013)

Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder
por: Wang, Fei, et al.
Publicado: (2022)

General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation
por: Yam, Mun Fei, et al.
Publicado: (2018)

Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform
por: Liu, Ran, et al.
Publicado: (2013)

Effects of Huolisu Oral Solution on Depression-Like Behavior in Rats: Neurotransmitter and HPA Axis
por: Xiao, Min, et al.
Publicado: (2022)

Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients
por: Wei, HongYan, et al.
Publicado: (2021)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen, Jian-jun, et al.
Publicado: (2018)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Evaluation on monoamine neurotransmitters changes in depression rats given with sertraline, meloxicam or/and caffeic acid
por: Huang, Dan, et al.
Publicado: (2018)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Seminal plasma metabolomics approach for the diagnosis of unexplained male infertility
por: Qiao, Shanlei, et al.
Publicado: (2017)

Age-specific urinary metabolite signatures and functions in patients with major depressive disorder
por: Chen, Jian-Jun, et al.
Publicado: (2019)

The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
por: Davis, Sarah E., et al.
Publicado: (2023)

The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease
por: Wang, Jun, et al.
Publicado: (2023)

Differential Gut Microbiota Compositions Related With the Severity of Major Depressive Disorder
por: Zhong, Qi, et al.
Publicado: (2022)

Plasma complement component 4 increases in patients with major depressive disorder
por: Wei, Jinxue, et al.
Publicado: (2017)

Untargeted Metabolomics Analysis Revealed the Major Metabolites in the Seeds of four Polygonatum Species
por: Qi, Jianjun, et al.
Publicado: (2022)

The significance of routine biochemical markers in patients with major depressive disorder
por: Peng, You-Fan, et al.
Publicado: (2016)

Targeted neurotransmitter metabolomics profiling of oleanolic acid in the treatment of spontaneously hypertensive rats
por: Yu, Ruixue, et al.
Publicado: (2019)

A Pilot Study on Plasma and Urine Neurotransmitter Levels in Children with Tic Disorders
por: Qian, Qiao-Qiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_midsrpn85lfpmc5gv72f01akkn